Latest Expert Opinions

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
November 14, 2019
(A Top Pick May 07/19, Up 0.1%) Fixed resin issue, and had a blowout quarter. Macro uncertainty has had an impact. Checked back organic growth based on economic environment. Would be optimistic on the name if we get a phase 1 trade deal.
Show full opinionHide full opinion
(A Top Pick May 07/19, Up 0.1%) Fixed resin issue, and had a blowout quarter. Macro uncertainty has had an impact. Checked back organic growth based on economic environment. Would be optimistic on the name if we get a phase 1 trade deal.
DON'T BUY
DON'T BUY
November 14, 2019
Competition has picked up, and there aren't as many orders to go around. Dropping delivery numbers, struggling to meet earnings expectations, and so volatility is increasing. Turnaround may take a while. Be cautious. Yield is 6%.
Show full opinionHide full opinion
Competition has picked up, and there aren't as many orders to go around. Dropping delivery numbers, struggling to meet earnings expectations, and so volatility is increasing. Turnaround may take a while. Be cautious. Yield is 6%.
HOLD
HOLD
November 14, 2019
Canadian insurers have been the winners this year. Volatile for a while, but the stock has rallied. Growing by mid-single digit EPS, 13-14% ROE, growing dividend, trading at 1.1x book value. Just hold it for the dividend and ride it. No more catalysts this year, but it will eventually get into the 30s. (Analysts’ price target is $29.54)
Show full opinionHide full opinion
Manulife Financial (MFC-T)
November 14, 2019
Canadian insurers have been the winners this year. Volatile for a while, but the stock has rallied. Growing by mid-single digit EPS, 13-14% ROE, growing dividend, trading at 1.1x book value. Just hold it for the dividend and ride it. No more catalysts this year, but it will eventually get into the 30s. (Analysts’ price target is $29.54)
WATCH
WATCH
November 14, 2019
One challenge is the margin on movies makes it hard to make money. Movie going is slowing down. Better opportunities elsewhere. Free cash flow is being reinvested in things that may or may not work. Dividend may be safe, but there's no growth.
Show full opinionHide full opinion
Cineplex Inc (CGX-T)
November 14, 2019
One challenge is the margin on movies makes it hard to make money. Movie going is slowing down. Better opportunities elsewhere. Free cash flow is being reinvested in things that may or may not work. Dividend may be safe, but there's no growth.
WEAK BUY
WEAK BUY
November 14, 2019
Great story. They're great at price increases and sourcing new products. Last year has been a bit slower. Rebalancing their products. Expansion in South America is smart. Great dividend, own for a long time. Reasonable valuation at these levels.
Show full opinionHide full opinion
Dollarama Inc. (DOL-T)
November 14, 2019
Great story. They're great at price increases and sourcing new products. Last year has been a bit slower. Rebalancing their products. Expansion in South America is smart. Great dividend, own for a long time. Reasonable valuation at these levels.
BUY
BUY
November 14, 2019
Asset light, lots of free cash. Rerating in the future. What gave him pause a year ago was that volumes were as good as they'd ever been. Can still grow organically and through acquisition. Good long-term buy for free cash flow, dividend growth, and compelling valuation.
Show full opinionHide full opinion
Asset light, lots of free cash. Rerating in the future. What gave him pause a year ago was that volumes were as good as they'd ever been. Can still grow organically and through acquisition. Good long-term buy for free cash flow, dividend growth, and compelling valuation.
BUY
BUY
November 14, 2019
Impressed with last quarter and their acquisition. Turned it around. Created a lot of value for shareholders. Favours Descartes Systems, but still worthy of holding if you want to own one of the consolidators. (Analysts’ price target is $45.00)
Show full opinionHide full opinion
Enghouse Systems (ENGH-T)
November 14, 2019
Impressed with last quarter and their acquisition. Turned it around. Created a lot of value for shareholders. Favours Descartes Systems, but still worthy of holding if you want to own one of the consolidators. (Analysts’ price target is $45.00)